Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of topical abafungin for interdigital tinea pedis
2006-001263-32Phase 3Completed
- Sponsor
- York Pharma
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of abafungin in Athlete's foot (3 arms), sponsored by York Pharma. Primary endpoint: Effective Treatment at day 43. Started Jun 2006; status: completed.
02
Drugs
abafungin
03
Conditions
Athlete's foot
Beyond the preview
Go deeper on 2006-001263-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001263-32.